Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular Degeneration

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Age-related Macular Degeneration
Interventions
DRUG

Bevacizumab

A single intravitreal injection of 1.25 mg of bevacizumab (0.05 mL of solution prepared from Avastin, 100 mg/4 mL vial) was performed within 2 weeks after PDT treatment.

Trial Locations (1)

860-8556

Department of Ophthalmology and Visual Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto

All Listed Sponsors
lead

Kumamoto University

OTHER

NCT01032109 - Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular Degeneration | Biotech Hunter | Biotech Hunter